Skip to content

Early Usage of Bakri Ballon in Managing Postpartum Hemorrhage

Early Usage of Bakri Postpartum Ballon is More Effective for the Management of Postpartum Hemorrhage

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02861482
Enrollment
472
Registered
2016-08-10
Start date
2015-01-31
Completion date
2016-03-31
Last updated
2016-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postpartum Hemorrhage

Keywords

PPH, Bakri Ballon

Brief summary

Postpartum hemorrhage (PPH) is the top reason for maternal deaths in China. The four major causes of PPH include uterine atony, genital tract laceration, placenta factors and systemic medical disorders (including inherited and acquired coagulopathy). Management of PPH contains the application of uterotonic agents, using hemostasis agents, transfusion of blood component products, conservative procedures (intrauterine packing or balloon tamponade, compression sutures, vascular ligation and uterine artery embolization using sponges), and even hysterectomy. The Bakri Balloon has attained its efficacy and popularity ever since it was invented by Doctor YN. Bakri. Although it is recommended by many countries as a routine procedure for PPH management, the Bakri Balloon is not yet a first choice in China due to lack in clinical data of preventive usage. The aim of this study is to prove the efficacy and safety of the Bakri Balloon in early management of PPH.

Detailed description

Data of 472 patients from 20 different hospitals had a Bakri balloon tamponade. Enrolled patients would follow the next process: assessment of blood loss intrapartum and 2 hours postpartum; laying the Bakri Balloon; assessment of blood loss, uterine contraction and complications after Bakri Balloon tamponade; further conservative surgical measures (uterine placation (B-lynch suture), arterial embolization; artery ligation; cervical cerclage) or even hysterectomy if necessary; recording the puerperium infection and involution of uterus. Data were analyzed by SPSS 20.0 database. The results were expressed as mean ± standard deviations or median with interquartile range. Differences between groups were assessed by Student's unpaired t test, Mann-Whitney U test, or Chi-square test as appropriate. Correlation analysis was performed using the Spearman rank correlation method. To identify independent relationships and adjust the effects of covariates, multiple linear regression analyses were performed. P values of \<0.05 were considered significant.

Interventions

Gradually increase the liquid volume inside Bakri Balloon to 250-500ml until bleeding is decreased or stopped

DRUGOxytocin

using oxytocin(usage:20IU oxytocin in 500ml lactated Ringer's, ivgtt to a maximum of 60IU) for the first step when dealing with PPH before laying Bakri Balloon

DRUGHemabate

using Hemabate (usage:250-500ug im) for the first step when dealing with PPH before laying Bakri Balloon

DRUGDuratocin

using Duratocin (usage:100ug iv) for the first step when dealing with PPH before laying Bakri Balloon

continuous uterine massage for the first step when dealing with PPH before laying Bakri Balloon

PROCEDUREB-lynch Suture

One of conservative surgical procedures if Bakri Balloon didn't work

PROCEDUREUterine Artery Embolization using sponges

One of conservative surgical procedures if Bakri Balloon didn't work

One of conservative surgical procedures if Bakri Balloon didn't work

PROCEDUREHysterectomy

Hysterectomy with all the above measures not working

transfusion of blood product if necessary no matter which surgical procedure has been taken

Sponsors

First Affiliated Hospital, Sun Yat-Sen University
CollaboratorOTHER
Third Affiliated Hospital, Sun Yat-Sen University
CollaboratorOTHER
Sixth Affiliated Hospital, Sun Yat-sen University
CollaboratorOTHER
The Third Affiliated Hospital of Guangzhou Medical University
CollaboratorOTHER
Guangzhou Women and Children's Medical Center
CollaboratorOTHER
Huadu District People's Hospital of Guangzhou
CollaboratorOTHER
Shenzhen Maternity & Child Healthcare Hospital
CollaboratorOTHER
Dongguan Maternity & Child Health Hospital
CollaboratorUNKNOWN
Zhuhai Maternity & Child Healthcare Hospital
CollaboratorUNKNOWN
The First Maternity & Child Healthcare Hospital of Huizhou
CollaboratorUNKNOWN
Nanhai Women's and Children's Hospital
CollaboratorUNKNOWN
Jiangmen Maternity & Child Health Care Hospital
CollaboratorUNKNOWN
The Third Affiliated Hospital of Southern Medical University
CollaboratorOTHER_GOV
Southern Medical University, China
CollaboratorOTHER
Zhongshan Dongsheng hospital
CollaboratorUNKNOWN
Xiaolan People's Hospital of Zhongshan
CollaboratorUNKNOWN
The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine
CollaboratorOTHER
Baoan District People's Hospital of Shenzhen
CollaboratorUNKNOWN
Zengcheng District People's Hospital of Guangzhou
CollaboratorUNKNOWN
Dongyu Wang
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
19 Years to 47 Years
Healthy volunteers
No

Inclusion criteria

* Women with vaginal or cesarean delivery; * PPH caused by: Uterine Atony, Placenta Factors, Coagulation disorders, Hematological disorders, Hepatic diseases, Obstetric DIC; * Not reacting well to continuous uterine massage or uterotonic agents including oxytocin (0.04IU/L ivgtt to a maximum of 60IU), Hemabate (250-500ug im) and Duratocin (100ug iv); * Without other conservative surgical treatment(uterine compression suture, internal arterial embolism; vascular ligation); * Signing the informed consents;

Exclusion criteria

* Has undergone or will undergo conservative surgical treatment(uterine compression suture, international arterial embolism; artery ligation); * Impaired soft birth canal injury; * Untreated uterine deformity; * Definite indication for uterectomy.

Design outcomes

Primary

MeasureTime frame
Blood loss after Bakri Ballon temponadefrom using Bakri Ballon Temponade to remove of Bakri Balloon Temponade with the interval ranging from 24hrs to 51hrs

Secondary

MeasureTime frame
Ratio of Bakri Ballon only without other invasive measures in succeeding controlling PPH to the number of casesFrom delivery to remove of Bakri Balloon Temponade with the interval ranging from 24hrs to 51hrs

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026